KRAS and neoplasm: The characteristics of the KRAS G12C mutation revealed two potentially novel findings: the higher prevalence of the KRAS G12C mutation in distal (left-sided tumours) contrary to other KRAS mutations and the higher prevalence of the KRAS G12C mutation in brain metastases compared to other KRAS mutations.